Try our Advanced Search for more refined results

Sandoz Can't Expand Xarelto Damages Claim Against Bayer

By Jamie Lennox ( October 7, 2025, 5:06 PM BST) -- A London court said Tuesday that Bayer's mindset in seeking interim injunctions to protect its now-revoked patent for the blood-thinning drug Xarelto "makes no difference" to Sandoz's claim for damages, refusing to allow the generic drugmaker to expand its request....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies